🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

99 results for “Lakefront Biotherapeutics NV” Clear

  1. GLPG0555

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  2. GLPG0555 solid dispersion

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  3. GLPG0634

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    3 trials

  4. GLPG0634

    Lakefront Biotherapeutics NV

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  5. GLPG0634 100mg capsule once a day for 10 days

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  6. GLPG0634 50 mg

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  7. GLPG0778

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  8. GLPG0974

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  9. GLPG1205

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  10. GLPG1205 50mg q.d.

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  11. GLPG1205 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  12. GLPG1205 single ascending doses, oral suspension

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  13. GLPG1690

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    2 trials

  14. GLPG1690 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  15. GLPG1690 single ascending doses

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  16. GLPG1837 500 mg

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  17. GLPG1837 single ascending doses

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  18. GLPG1972

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  19. GLPG1972 - A

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  20. GLPG1972 600 mg oral solution fasted

    Lakefront Biotherapeutics NV

    Osteoarthritis

    phase 1 small molecule completed

    1 trial

  21. GLPG1972 cohort 1

    Lakefront Biotherapeutics NV

    Osteoarthritis

    phase 1 small molecule completed

    1 trial

  22. GLPG1972 film-coated tablets

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  23. GLPG1972 single ascending doses

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  24. GLPG2222 single dose

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources